Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 42

Trial Status

Completed3
Terminated1

Role Distribution

Principal Investigator2
Other Roles2
PI Rate50%

Activity Timeline

Clinical Trials (4)

NCT00307125Phase 2Completed
Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies
de Novo HLA Antibodies DevelopmentGraft Function/SurvivalKidney Transplant+1 more
Studychair
NCT01034176Phase 4Completed
BK Treatment Study
BK Viremia
Principalinvestigator
NCT01437943Phase 4Terminated
Effect of Short Term Aliskiren Treatment in Kidney Transplant Patients
Kidney DiseaseKidney Failure, Chronic
Principalinvestigator

Research Network

Collaboration Network

9 collaborators·10 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

William Harmon, MD

Boston Children's Hospital

Similar
3 trials

Shared therapeutic areas:

Kidney Failure, Chronicde Novo HLA Antibodies DevelopmentGraft Function/Survival+3 more

Worked with same sponsors:

Clinical Trials in Organ TransplantationCooperative Clinical Trials in Pediatric Transplantation+1 more
Collaborated on 1 trial
Similarity Score64%

Mohamed H. Sayegh, MD

Brigham and Women's Hospital

Moderately Similar
2 trials

Shared therapeutic areas:

de Novo HLA Antibodies DevelopmentGraft Function/SurvivalKidney Transplant+1 more

Worked with same sponsors:

Clinical Trials in Organ TransplantationCooperative Clinical Trials in Pediatric Transplantation+1 more
Collaborated on 1 trial
Similarity Score44%

Laurence Turka, MD

Beth Israel Deaconess Medical Center

Related
1 trials

Shared therapeutic areas:

Kidney Transplantation

Worked with same sponsors:

Clinical Trials in Organ TransplantationImmune Tolerance Network (ITN)+1 more
Collaborated on 1 trial
Similarity Score14%

Kenneth Newell, MD, PhD

Emory University

Related
5 trials

Shared therapeutic areas:

Kidney Transplantation

Worked with same sponsors:

Clinical Trials in Organ TransplantationImmune Tolerance Network (ITN)+1 more
Collaborated on 1 trial
Similarity Score14%

HS Kim, M.D.

Sinchon severance hospital

Related
1 trials

Shared therapeutic areas:

Kidney Failure, Chronic
Similarity Score4%

SH Park, M.D.

St Vincent's Hospital

Related
1 trials

Shared therapeutic areas:

Kidney Failure, Chronic
Similarity Score4%

Hamid Gourabi, PhD

head of Royan Institute

Related
52 trials

Shared therapeutic areas:

Kidney Failure, Chronic
Similarity Score4%

YJ Lee, M.D.

Korea University

Related
1 trials

Shared therapeutic areas:

Kidney Failure, Chronic
Similarity Score4%

Ali MA Ismail, lecturer

Cairo University

Related
27 trials

Shared therapeutic areas:

Kidney Failure, Chronic
Similarity Score4%

CW Ko, M.D.

Kyungpook National University Hospital

Related
1 trials

Shared therapeutic areas:

Kidney Failure, Chronic
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT00307125Phase 2StudyChair

Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies

de Novo HLA Antibodies DevelopmentGraft Function/SurvivalKidney Transplant+1 more
Completed
NCT01034176Phase 4PrincipalInvestigator

BK Treatment Study

BK Viremia
Completed
NCT01437943Phase 4PrincipalInvestigator

Effect of Short Term Aliskiren Treatment in Kidney Transplant Patients

Kidney DiseaseKidney Failure, Chronic
Terminated
NCT01516177StudyChair

Associating Renal Transplantation With the ITN Signature of Tolerance

Kidney Transplantation
Completed

All 4 trials loaded